Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1 Corrigendum in /10.3892/ijo.2019.4670

Abdelbaset‑Ismail,Ahmed; Pedziwiatr,Daniel; Schneider,Gabriela; Niklinski,Jacek; Charkiewicz,Radoslaw; Moniuszko,Marcin; Kucia,Magda; Ratajczak,Mariusz Z.

doi:10.3892/ijo.2016.3787

Pituitary sex hormones enhance the pro‑metastatic potential of human lung cancer cells by downregulating the intracellular expression of heme oxygenase‑1

Corrigendum in: /10.3892/ijo.2019.4670

Authors:
- Ahmed Abdelbaset‑Ismail
- Daniel Pedziwiatr
- Gabriela Schneider
- Jacek Niklinski
- Radoslaw Charkiewicz
- Marcin Moniuszko
- Magda Kucia
- Mariusz Z. Ratajczak
View Affiliations

Affiliations: Stem Cell Institute at James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA, Department of Clinical Molecular Biology, Medical University of Bialystok, Bialystok, Poland, Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Bialystok, Poland
Published online on: December 2, 2016 https://doi.org/10.3892/ijo.2016.3787
Pages: 317-328

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

We report that human lung cancer cell lines express functional receptors for pituitary sex hormones (SexHs) and respond to stimulation by follicle‑stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL). Expression of these receptors has also been confirmed in patient lung cancer samples at the mRNA level. Stimulation of human lung cancer cell lines with FSH, LH, or PRL stimulated migration and chemotaxis, and some cell lines responded by enhanced proliferation. Moreover, priming of human lung cancer cells by exposing them to pituitary SexHs resulted in enhanced seeding efficiency of injected human lung cancer cells into bone marrow, liver, and lungs in an immunodeficient mouse model. The chemotaxis of lung cancer cell lines corresponded with the activity of heme oxygenase‑1 (HO‑1), as stimulation of these cells by FSH, LH, and PRL downregulated its expression in a p38 MAPK‑dependent manner. Moreover, while downregulation of HO‑1 by the small‑molecule inhibitor tin protoporphyrin (SnPP) promoted migration, upregulation of HO‑1 by the small‑molecule activator cobalt protoporphyrin (CoPP) showed the opposite effect. Based on this finding, we propose that pituitary SexHs play a significant role in the pathogenesis of lung cancer, particularly when the blood level of FSH increases due to gonadal dysfunction with advanced age. Finally, we propose that upregulation of HO‑1 expression by a small‑molecule activator may be effective in controlling SexH‑induced cell migration in lung cancer.

View Figures

View References

1	van Kruchten M, van der Marel P, de Munck L, Hollema H, Arts H, Timmer-Bosscha H, de Vries E, Hospers G and Reyners A: Hormone receptors as a marker of poor survival in epithelial ovarian cancer. Gynecol Oncol. 138:634–639. 2015. View Article : Google Scholar : PubMed/NCBI
2	García-Cruz E, Piqueras M, Huguet J, Peri L, Izquierdo L, Musquera M, Franco A, Alvarez-Vijande R, Ribal MJ and Alcaraz A: Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment. BJU Int. 110:E541–E546. 2012. View Article : Google Scholar : PubMed/NCBI
3	García-Cruz E, Piqueras M, Ribal MJ, Huguet J, Serapiao R, Peri L, Izquierdo L and Alcaraz A: Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia. BJU Int. 110:E199–E202. 2012. View Article : Google Scholar : PubMed/NCBI
4	García-Cruz E, Carrión Puig A, García-Larrosa A, Sallent A, Castañeda-Argáiz R, Piqueras M, Ribal MJ, Leibar-Tamayo A, Romero-Otero J and Alcaraz A: Higher sex hormone-binding globulin and lower bioavailable testosterone are related to prostate cancer detection on prostate biopsy. Scand J Urol. 47:282–289. 2013. View Article : Google Scholar
5	Lønning PE: Poor-prognosis estrogen receptor-positive disease: Present and future clinical solutions. Ther Adv Med Oncol. 4:127–137. 2012. View Article : Google Scholar
6	Poniewierska-Baran A, Schneider G, Sun W, Abdelbaset-Ismail A, Barr FG and Ratajczak MZ: Human rhabdomyosarcoma cells express functional pituitary and gonadal sex hormone receptors: Therapeutic implications. Int J Oncol. 48:1815–1824. 2016.PubMed/NCBI
7	Abdelbaset-Ismail A, Borkowska S, Janowska-Wieczorek A, Tonn T, Rodriguez C, Moniuszko M, Bolkun L, Koloczko J, Eljaszewicz A, Ratajczak J, et al: Novel evidence that pituitary gonadotropins directly stimulate human leukemic cells-studies of myeloid cell lines and primary patient AML and CML cells. Oncotarget. 7:3033–3046. 2016.
8	Taggart DP, Gray CE, Bowman A, Faichney A and Davidson KG: Serum androgens and gonadotrophins in bronchial carcinoma. Respir Med. 87:455–460. 1993. View Article : Google Scholar : PubMed/NCBI
9	Huchon G and Akoun G: Endocrine secretions by bronchial tumors. Sem Hop. 55:180–188. 1979.In French. PubMed/NCBI
10	Siraj A, Desestret V, Antoine M, Fromont G, Huerre M, Sanson M, Camparo P, Pichon C, Planeix F, Gonin J, et al: Expression of follicle-stimulating hormone receptor by the vascular endothelium in tumor metastases. BMC Cancer. 13:2462013. View Article : Google Scholar : PubMed/NCBI
11	Chen M, Xu Y, Hao X, Zhang Y, Xu W and Lu B: The significance of serum sexual hormones' level in male patients with lung cancer. Zhongguo Fei Ai Za Zhi. 8:300–303. 2005.In Chinese. PubMed/NCBI
12	Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE and Soules MR: Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab. 81:2742–2745. 1996.PubMed/NCBI
13	Wang YJ, Wu JC, Lee SD, Tsai YT and Lo KJ: Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: A matched study with alcoholic cirrhotic men. Hepatogastroenterology. 38:531–534. 1991.PubMed/NCBI
14	Aasebø U, Bremnes RM, de Jong FH, Aakvaag A and Slørdal L: Pituitary-gonadal dysfunction in male patients with lung cancer. Association with serum inhibin levels. Acta Oncol. 33:177–180. 1994. View Article : Google Scholar : PubMed/NCBI
15	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
16	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
17	Mulshine JL, Treston AM, Brown PH, Birrer MJ and Shaw GL: Initiators and promoters of lung cancer. Chest. 103(Suppl): 4S–11S. 1993. View Article : Google Scholar : PubMed/NCBI
18	Schnabel PA and Junker K: Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia. Pathologe. 35:557–564. 2014.In German. View Article : Google Scholar : PubMed/NCBI
19	Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK: Non-small-cell lung cancers: A heterogeneous set of diseases. Nat Rev Cancer. 14:535–546. 2014. View Article : Google Scholar : PubMed/NCBI
20	Idowu MO and Powers CN: Lung cancer cytology: Potential pitfalls and mimics - a review. Int J Clin Exp Pathol. 3:367–385. 2010.PubMed/NCBI
21	Hall A: The cytoskeleton and cancer. Cancer Metastasis Rev. 28:5–14. 2009. View Article : Google Scholar : PubMed/NCBI
22	Caswell P and Norman J: Endocytic transport of integrins during cell migration and invasion. Trends Cell Biol. 18:257–263. 2008. View Article : Google Scholar : PubMed/NCBI
23	Adamiak M, Iv JB, Zhao J, Abdelbaset-Ismail A, Grubczak K, Borkowska S, Wysoczynski M and Ratajczak MZ: Downregulation of heme oxygenase 1 (HO-1) activity in hematopoietic cells enhances their engraftment after transplantation. Cell Transplant. Oct 16–2015.Epub ahead of print. PubMed/NCBI
24	Wysoczynski M, Ratajczak J, Pedziwiatr D, Rokosh G, Bolli R and Ratajczak MZ: Identification of heme oxygenase 1 (HO-1) as a novel negative regulator of mobilization of hematopoietic stem/progenitor cells. Stem Cell Rev. 11:110–118. 2015. View Article : Google Scholar :
25	Abdelbaset-Ismail A, Pedziwiatr D, Suszyńska E, Sluczanowska-Glabowska S, Schneider G, Kakar SS and Ratajczak MZ: Vitamin D3 stimulates embryonic stem cells but inhibits migration and growth of ovarian cancer and teratocarcinoma cell lines. J Ovarian Res. 9:262016. View Article : Google Scholar : PubMed/NCBI
26	Bhatt S, Stender JD, Joshi S, Wu G and Katzenellenbogen BS: OCT-4: A novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells. Oncogene. Apr 11–2016.Epub ahead of print. View Article : Google Scholar
27	Ratajczak MZ, Shin DM and Kucia M: Very small embryonic/epiblast-like stem cells: A missing link to support the germ line hypothesis of cancer development? Am J Pathol. 174:1985–1992. 2009. View Article : Google Scholar : PubMed/NCBI
28	Sławek S, Szmyt K, Fularz M, Dziudzia J, Boruczkowski M, Sikora J and Kaczmarek M: Pluripotency transcription factors in lung cancer - a review. Tumour Biol. 37:4241–4249. 2016. View Article : Google Scholar
29	Reiter MJ, Costello JE, Schwope RB, Lisanti CJ and Osswald MB: Review of commonly used serum tumor markers and their relevance for image interpretation. J Comput Assist Tomogr. 39:825–834. 2015. View Article : Google Scholar : PubMed/NCBI
30	Zhang W, Barger CJ, Link PA, Mhawech-Fauceglia P, Miller A, Akers SN, Odunsi K and Karpf AR: DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer. Epigenetics. 10:736–748. 2015. View Article : Google Scholar : PubMed/NCBI
31	Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, Brinton LA, et al Endogenous Hormones and Breast Cancer Collaborative Group: Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 14:1009–1019. 2013. View Article : Google Scholar : PubMed/NCBI
32	Sorenson GD, Pettengill OS, Brinck-Johnsen T, Cate CC and Maurer LH: Hormone production by cultures of small-cell carcinoma of the lung. Cancer. 47:1289–1296. 1981. View Article : Google Scholar : PubMed/NCBI
33	Rotondo F, Kovacs K, Macdonald RL, Prud'homme GJ, Latta E and Munoz D: Non-small cell bronchial carcinoma metastasizing into a prolactin-producing pituitary adenoma. Int J Surg Pathol. 21:68–71. 2013. View Article : Google Scholar
34	Hanna FW, Williams OM, Davies JS, Dawson T, Neal J and Scanlon MF: Pituitary apoplexy following metastasis of bronchogenic adenocarcinoma to a prolactinoma. Clin Endocrinol (Oxf). 51:377–381. 1999. View Article : Google Scholar
35	Abdelbaset-Ismail A, Suszynska M, Borkowska S, Adamiak M, Ratajczak J, Kucia M and Ratajczak MZ: Human haematopoietic stem/progenitor cells express several functional sex hormone receptors. J Cell Mol Med. 20:134–146. 2016. View Article : Google Scholar :
36	Mierzejewska K, Borkowska S, Suszynska E, Suszynska M, Poniewierska-Baran A, Maj M, Pedziwiatr D, Adamiak M, Abdel-Latif A, Kakar SS, et al: Hematopoietic stem/progenitor cells express several functional sex hormone receptors - novel evidence for a potential developmental link between hematopoiesis and primordial germ cells. Stem Cells Dev. 24:927–937. 2015. View Article : Google Scholar : PubMed/NCBI
37	Virchow R: Editorial Archive fuer pathologische. Anatomie und Physiologie fuer klinische Medizin. 8:23–54. 1855.In German.
38	Conheim J: Congenitales, quergestreiftes muskelsarkon der nireren. Virchows Arch. 65:64–69. 1875.In German. View Article : Google Scholar
39	Ratajczak MZ, Shin DM, Liu R, Marlicz W, Tarnowski M, Ratajczak J and Kucia M: Epiblast/germ line hypothesis of cancer development revisited: Lesson from the presence of Oct-4⁺ cells in adult tissues. Stem Cell Rev. 6:307–316. 2010. View Article : Google Scholar : PubMed/NCBI
40	Ratajczak MZ, Zuba-Surma EK, Wysoczynski M, Ratajczak J and Kucia M: Very small embryonic-like stem cells: Characterization, developmental origin, and biological significance. Exp Hematol. 36:742–751. 2008. View Article : Google Scholar : PubMed/NCBI
41	Shin DM, Liu R, Klich I, Wu W, Ratajczak J, Kucia M and Ratajczak MZ: Molecular signature of adult bone marrow-purified very small embryonic-like stem cells supports their developmental epiblast/germ line origin. Leukemia. 24:1450–1461. 2010. View Article : Google Scholar : PubMed/NCBI
42	Reiche EM, Nunes SO and Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol. 5:617–625. 2004. View Article : Google Scholar : PubMed/NCBI